Elimination of severe height growth suppression caused by treatment with betamethasone after switching to ACTH-depot in chronic bronchial asthma.
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy*; D001623:Betamethasone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001827:Body Height; D003692:Delayed-Action Preparations; D005260:Female; D006130:Growth Disorders / Q000139:chemically induced* / Q000517:prevention & control; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007328:Insulin
D003692:Delayed-Action Preparations; D007328:Insulin; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D001623:Betamethasone; D006909:Hydroxyproline